JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komalahiranya, A.
Right arrow Articles by Volle, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komalahiranya, A.
Right arrow Articles by Volle, R. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 139, Issue 3, 304-311, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


ALTERATIONS OF TRANSMISSION IN SYMPATHETIC GANGLIA TREATED WITH A SULFHYDRYL-GROUP INHIBITOR, N-ETHYLMALEIMIDE (NEM)

Amnuay Komalahiranya 1 and Robert L. Volle 1

1 Department of Pharmacology, Schools of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

N-Ethylmaleimide (NEM) produced a series of changes in the responses of the superior cervical ganglion to stimulation of the preganglionic nerve and injected ganglionic stimulating drugs. On the basis of the time-courses of the changes, these alterations could be grouped into three divisions: viz., immediate, late, and delayed. The immediate change in ganglionic function produced by NEM was an enhancement of the postganglionic spike and a depression of the responses evoked by acetylcholine (ACh), potassium chloride (KCl), or tetramethylammonium ions (TMA). The responses of denervated ganglia to these agents were blocked also by NEM. Conversely, the late change produced by NEM consisted of an enhancement of the responses of the ganglia to the ganglionic stimulants at a time when the response to stimulation of the preganglionic nerve was depressed or even abolished. A similar late change was produced in the responses of denervated ganglia to the stimulating drugs. Furthermore, retrograde firing along the preganglionic nerve evoked by KCl was enhanced by NEM. The delayed change in ganglionic activity was the occurrence of spontaneous pre- and postganglionic asynchronous discharges. The asynchronous firing of the postganglionic nerve was not affected by atropine, hexamethonium, or mecamylamine; was enhanced by d-tubocurarine and tetraethylammonium; and was blocked by calcium chloride and magnesium chloride. Hexamethonium blocked the excitatory action of d-tubocurarine. The preganglionic firing, although blocked by calcium ions, was not affected by any of the ganglionic blocking agents.

These findings are compared with the changes in ganglionic activity which occur in sympathetic ganglia deprived of calcium ions.

Submitted on November 5, 1962
Accepted on December 14, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.